Works matching DE "BISPECIFIC antibodies"
Results: 1221
Immunotherapy for triple negative breast cancer: the end of the beginning or the beginning of the end?
- Published in:
- Cancer & Metastasis Reviews, 2022, v. 41, n. 3, p. 465, doi. 10.1007/s10555-022-10060-4
- By:
- Publication type:
- Article
Immunotherapies for pediatric cancer: current landscape and future perspectives.
- Published in:
- Cancer & Metastasis Reviews, 2019, v. 38, n. 4, p. 573, doi. 10.1007/s10555-019-09819-z
- By:
- Publication type:
- Article
Three-month outcomes of treatment with faricimab or aflibercept for neovascular age-related macular degeneration: a propensity score matching study in a Japanese population.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2024, v. 262, n. 12, p. 3971, doi. 10.1007/s00417-024-06582-y
- By:
- Publication type:
- Article
Faricimab for neovascular age-related macular degeneration and diabetic macular edema: from preclinical studies to phase 3 outcomes.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2024, v. 262, n. 11, p. 3437, doi. 10.1007/s00417-024-06531-9
- By:
- Publication type:
- Article
Extending Linker Sequences between Antigen-Recognition Modules Provides More Effective Production of Bispecific Nanoantibodies in the Periplasma of E. coli.
- Published in:
- Biochemistry (00062979), 2024, v. 89, n. 5, p. 933, doi. 10.1134/S0006297924050134
- By:
- Publication type:
- Article
State-of-the-Art Approaches to Heterologous Expression of Bispecific Antibodies Targeting Solid Tumors.
- Published in:
- Biochemistry (00062979), 2023, v. 88, n. 9, p. 1215, doi. 10.1134/S0006297923090031
- By:
- Publication type:
- Article
The Use of Faricimab for Neovascular Age-Related Macular Degeneration and Diabetic Macular Oedema in Real Clinical Practice.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Teclistamab Monotherapy for the Treatment of Adult Patients with Relapsed and Refractory Multiple Myeloma.
- Published in:
- touchREVIEWS in Oncology & Haematology, 2023, v. 19, n. 1, p. 46, doi. 10.17925/OHR.2023.19.1.46
- By:
- Publication type:
- Article
Clinical experience with tebentafusp in metastatic uveal melanoma.
- Published in:
- Oncolog-Hematolog, 2024, v. 69, n. 4, p. 23
- By:
- Publication type:
- Article
Emerging Immunotherapies for Advanced Non-Small-Cell Lung Cancer.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 128, doi. 10.3390/vaccines13020128
- By:
- Publication type:
- Article
Emerging Immunotherapies for Advanced Non-Small-Cell Lung Cancer.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 128, doi. 10.3390/vaccines13020128
- By:
- Publication type:
- Article
Turning Cancer Immunotherapy to the Emerging Immune Checkpoint TIGIT: Will This Break Through the Limitations of the Legacy Approach?
- Published in:
- Vaccines, 2024, v. 12, n. 12, p. 1306, doi. 10.3390/vaccines12121306
- By:
- Publication type:
- Article
HER2-CD3-Fc Bispecific Antibody-Encoding mRNA Delivered by Lipid Nanoparticles Suppresses HER2-Positive Tumor Growth.
- Published in:
- Vaccines, 2024, v. 12, n. 7, p. 808, doi. 10.3390/vaccines12070808
- By:
- Publication type:
- Article
New Emerging Targets in Cancer Immunotherapy: The Role of B7-H3.
- Published in:
- Vaccines, 2024, v. 12, n. 1, p. 54, doi. 10.3390/vaccines12010054
- By:
- Publication type:
- Article
Development of a Bispecific Nanobody Targeting CD20 on B-Cell Lymphoma Cells and CD3 on T Cells.
- Published in:
- Vaccines, 2022, v. 10, n. 8, p. 1335, doi. 10.3390/vaccines10081335
- By:
- Publication type:
- Article
Antibody-Drug Conjugates: Functional Principles and Applications in Oncology and Beyond.
- Published in:
- Vaccines, 2021, v. 9, n. 10, p. 1111, doi. 10.3390/vaccines9101111
- By:
- Publication type:
- Article
Bispecific Antibodies: A Smart Arsenal for Cancer Immunotherapies.
- Published in:
- Vaccines, 2021, v. 9, n. 7, p. 724, doi. 10.3390/vaccines9070724
- By:
- Publication type:
- Article
Current Immunotherapy Approaches in Non-Hodgkin Lymphomas.
- Published in:
- Vaccines, 2020, v. 8, n. 4, p. 708, doi. 10.3390/vaccines8040708
- By:
- Publication type:
- Article
Culture media and format alter cellular composition and barrier integrity of porcine colonoid-derived monolayers.
- Published in:
- Tissue Barriers, 2024, v. 12, n. 2, p. 1, doi. 10.1080/21688370.2023.2222632
- By:
- Publication type:
- Article
Targeting EGFR Exon 20 Insertion-mutated Cancers – New Perspectives in Head and Neck Cancers – Lessons to Learn from Non-small Cell Carcinoma (NSCLC).
- Published in:
- Medicina Moderna, 2022, v. 29, n. 3, p. 181, doi. 10.31689/rmm.2022.29.3.181
- By:
- Publication type:
- Article
Nanobody-Based EGFR-Targeting Immunotoxins for Colorectal Cancer Treatment.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 7, p. 1042, doi. 10.3390/biom13071042
- By:
- Publication type:
- Article
Not-So-Sweet Dreams: Plasma and IgG N-Glycome in the Severe Form of the Obstructive Sleep Apnea.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 6, p. 880, doi. 10.3390/biom13060880
- By:
- Publication type:
- Article
Shortened Hinge Design of Fab x sdAb-Fc Bispecific Antibodies Enhances Redirected T-Cell Killing of Tumor Cells.
- Published in:
- Biomolecules (2218-273X), 2022, v. 12, n. 10, p. N.PAG, doi. 10.3390/biom12101331
- By:
- Publication type:
- Article
Editorial for the Special Issue: "State-of-Art in Protein Engineering".
- Published in:
- 2022
- By:
- Publication type:
- Editorial
A path forward to improving the specificity of immunotherapies.
- Published in:
- Clinical & Translational Medicine, 2022, v. 12, n. 9, p. 1, doi. 10.1002/ctm2.1051
- By:
- Publication type:
- Article
CD47‐SIRPα blocking‐based immunotherapy: Current and prospective therapeutic strategies.
- Published in:
- Clinical & Translational Medicine, 2022, v. 12, n. 8, p. 1, doi. 10.1002/ctm2.943
- By:
- Publication type:
- Article
PD‐L1/TIGIT bispecific antibody showed survival advantage in animal model.
- Published in:
- Clinical & Translational Medicine, 2022, v. 12, n. 5, p. 1, doi. 10.1002/ctm2.754
- By:
- Publication type:
- Article
HER2/PD1 bispecific antibody in IgG4 subclass with superior anti‐tumour activities.
- Published in:
- Clinical & Translational Medicine, 2022, v. 12, n. 4, p. 1, doi. 10.1002/ctm2.791
- By:
- Publication type:
- Article
Protocol of a first-in-human clinical trial to evaluate the safety, tolerability, and preliminary efficacy of the bispecific CD276xCD3 antibody CC-3 in patients with colorectal cancer (CoRe_CC-3).
- Published in:
- Frontiers in Oncology, 2024, p. 01, doi. 10.3389/fonc.2024.1351901
- By:
- Publication type:
- Article
New treatment options in elderly patients with Diffuse Large B-cell Lymphoma.
- Published in:
- Frontiers in Oncology, 2023, p. 01, doi. 10.3389/fonc.2023.1214026
- By:
- Publication type:
- Article
T-cell redirecting therapies for B-cell non-Hodgkin lymphoma: recent progress and future directions.
- Published in:
- Frontiers in Oncology, 2023, p. 01, doi. 10.3389/fonc.2023.1168622
- By:
- Publication type:
- Article
Identification of immunotherapy and radioimmunotherapy targets on desmoplastic small round cell tumors.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1104693
- By:
- Publication type:
- Article
Bispecific antibodies targeting CTLA-4: game-changer troopers in cancer immunotherapy.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1155778
- By:
- Publication type:
- Article
Serum albumin binding knob domains engineered within a V<sub>H</sub> framework III bispecific antibody format and as chimeric peptides.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1170357
- By:
- Publication type:
- Article
Design and selection of optimal ErbB-targeting bispecific antibodies in pancreatic cancer.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1168444
- By:
- Publication type:
- Article
IgG-based B7-H3xCD3 bispecific antibody for treatment of pancreatic, hepatic and gastric cancer.
- Published in:
- Frontiers in Immunology, 2023, p. 01, doi. 10.3389/fimmu.2023.1163136
- By:
- Publication type:
- Article
Effect of monovalency on anti-contactin-1 IgG4.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1021513
- By:
- Publication type:
- Article
CAR-T cell therapy in multiple myeloma: Current limitations and potential strategies.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1101495
- By:
- Publication type:
- Article
Generation of bispecific antibodies by structure-guided redesign of IgG constant regions.
- Published in:
- Frontiers in Immunology, 2023, v. 13, p. 01, doi. 10.3389/fimmu.2022.1063002
- By:
- Publication type:
- Article
CHI3L1 enhances melanoma lung metastasis via regulation of T cell co-stimulators and CTLA-4/B7 axiss.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1056397
- By:
- Publication type:
- Article
PD-1/LAG-3 bispecific antibody potentiates T cell activation and increases antitumor efficacy.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1047610
- By:
- Publication type:
- Article
TriTECM: A tetrafunctional T-cell engaging antibody with built-in risk mitigation of cytokine release syndrome.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.1051875
- By:
- Publication type:
- Article
Generation of high affinity ICAM-1-specific nanobodies and evaluation of their suitability for allergy treatment.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.1022418
- By:
- Publication type:
- Article
Activation of distinct antiviral T-cell immunity: A comparison of bi- and trispecific T-cell engager antibodies with a chimeric antigen receptor targeting HBV envelope proteins.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1029214
- By:
- Publication type:
- Article
Bispecific antibody-targeted T-cell therapy for acute myeloid leukemia.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.899468
- By:
- Publication type:
- Article
Current landscape and future directions of bispecific antibodies in cancer immunotherapy.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1035276
- By:
- Publication type:
- Article
Immunotherapeutic progress and application of bispecific antibody in cancer.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1020003
- By:
- Publication type:
- Article
Editorial: Novel treatments for diffuse large B-cell lymphoma: The post-CART era.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.1002615
- By:
- Publication type:
- Article
Role of Bispecific Antibodies in Relapsed/Refractory Diffuse Large B-Cell Lymphoma in the CART Era.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.909008
- By:
- Publication type:
- Article
Next Generation CD40 Agonistic Antibodies for Cancer Immunotherapy.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.940674
- By:
- Publication type:
- Article